Two patients, 1 with chronic active hepatitis, the other with Goodpasture's syndrome, became HBsAg-positive after the start of immunosuppressive drug therapy. At the same time of presentation, sera contained anti-HBc antibodies of IgM and IgG class in the absence of HBsAg or anti-HBs and immunofluorescent studies of liver biopsy specimens showed core antigen in the nuclei of liver cells. It is suggested that these findings reflected an unusual pattern of hepatitis B virus infection with a very low level of viral replication and that the appearance of HBsAg in both serum and liver cells after immunosuppressive drug therapy was due to reactivation of this infection, possibly as a result of changes in levels of antibodies which suppress viral ...
New therapeutic options like monoclonal antibodies (anti-CD20/rituximab) and hematopoietic stem cell...
The aim of the study was to evaluate clinical and virological differences in HBV reactivation betwee...
Hepatitis B virus (HBV) persistence is at the basis of HBV reactivation as a consequence of chemothe...
Two patients, 1 with chronic active hepatitis, the other with Goodpasture's syndrome, became HBsAg-p...
Reactivation of hepatitis B virus (HBV) replication, anabrupt increase or reappearance of serum HBV ...
Antibody to the hepatitis B core antigen (anti-HBc) was detected in sera from 6 (19%) of 32 patients...
Reactivation of hepatitis B virus (HBV) infection is in-creasingly recognized as a complication of i...
AIM: To present the characteristics and the course of a series of anti- hepatitis B virus core antib...
Reactivation of hepatitis B virus (HBV) replication is characterized by increased HBV-DNA serum valu...
Reactivation of hepatitis B virus (HBV) infection has been described in patients with HBsAg negative...
Eighty-eight consecutive hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) posit...
Eighty-eight consecutive hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) posit...
Seventy consecutive HBsAg- and HBeAg-positive patients with biopsy-proven chronic hepatitis were fol...
# The Author(s) 2014. This article is published with open access at Springerlink.com Abstract After ...
Loss of HBsAg and development of surface and core antibodies represent clinical cure. However, recen...
New therapeutic options like monoclonal antibodies (anti-CD20/rituximab) and hematopoietic stem cell...
The aim of the study was to evaluate clinical and virological differences in HBV reactivation betwee...
Hepatitis B virus (HBV) persistence is at the basis of HBV reactivation as a consequence of chemothe...
Two patients, 1 with chronic active hepatitis, the other with Goodpasture's syndrome, became HBsAg-p...
Reactivation of hepatitis B virus (HBV) replication, anabrupt increase or reappearance of serum HBV ...
Antibody to the hepatitis B core antigen (anti-HBc) was detected in sera from 6 (19%) of 32 patients...
Reactivation of hepatitis B virus (HBV) infection is in-creasingly recognized as a complication of i...
AIM: To present the characteristics and the course of a series of anti- hepatitis B virus core antib...
Reactivation of hepatitis B virus (HBV) replication is characterized by increased HBV-DNA serum valu...
Reactivation of hepatitis B virus (HBV) infection has been described in patients with HBsAg negative...
Eighty-eight consecutive hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) posit...
Eighty-eight consecutive hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) posit...
Seventy consecutive HBsAg- and HBeAg-positive patients with biopsy-proven chronic hepatitis were fol...
# The Author(s) 2014. This article is published with open access at Springerlink.com Abstract After ...
Loss of HBsAg and development of surface and core antibodies represent clinical cure. However, recen...
New therapeutic options like monoclonal antibodies (anti-CD20/rituximab) and hematopoietic stem cell...
The aim of the study was to evaluate clinical and virological differences in HBV reactivation betwee...
Hepatitis B virus (HBV) persistence is at the basis of HBV reactivation as a consequence of chemothe...